UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study (Q42067941)
Jump to navigation
Jump to search
scientific article published on 6 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study |
scientific article published on 6 June 2012 |
Statements
1 reference
UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study (English)
1 reference
Y-H Wang
1 reference
M Trucksis
1 reference
J J McElwee
1 reference
P H Wong
1 reference
C Maciolek
1 reference
C D Thompson
1 reference
T Prueksaritanont
1 reference
G C Garrett
1 reference
R Declercq
1 reference
E Vets
1 reference
K J Willson
1 reference
R C Smith
1 reference
J A Klappenbach
1 reference
G J Opiteck
1 reference
J A Tsou
1 reference
C Gibson
1 reference
T Laethem
1 reference
P Panorchan
1 reference
M Iwamoto
1 reference
P M Shaw
1 reference
J A Wagner
1 reference
J C Harrelson
1 reference
6 June 2012
1 reference
1 reference
96-102
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference